HOTH vs STE · rev $1.24B vs P/E 25, rev $5.46B
Hoth Therapeutics Inc (HOTH) versus STERIS plc (STE) — a side-by-side from cached financials, not a winner call.
Hoth Therapeutics Inc (HOTH) is a biotechnology company listed on US.
STERIS plc (STE) is a medical devices company listed on NYSE.
Latest reported HOTH revenue for 2024-03-31 was $1.24B. Net income was -$2.1M. HOTH currently screens at market cap $15.5M.
Latest reported STE revenue for 2025-03-31 was $5.46B. Net income was $616.1M. Revenue was up 284.6% from 2024-03-31 to 2025-03-31. STE currently screens at market cap $19.43B and trailing P/E 25.1.
HOTH currently screens at market cap $15.5M. STE currently screens at market cap $19.43B and trailing P/E 25.1.
Not investment advice. Open the HOTH and STE stock pages for the full models.
Not investment advice.